322 related articles for article (PubMed ID: 22391115)
1. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.
Lu TX; Sherrill JD; Wen T; Plassard AJ; Besse JA; Abonia JP; Franciosi JP; Putnam PE; Eby M; Martin LJ; Aronow BJ; Rothenberg ME
J Allergy Clin Immunol; 2012 Apr; 129(4):1064-75.e9. PubMed ID: 22391115
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets.
Lu S; Mukkada VA; Mangray S; Cleveland K; Shillingford N; Schorl C; Brodsky AS; Resnick MB
PLoS One; 2012; 7(7):e40676. PubMed ID: 22815788
[TBL] [Abstract][Full Text] [Related]
3. Pediatric eosinophilic esophagitis is associated with changes in esophageal microRNAs.
Zahm AM; Menard-Katcher C; Benitez AJ; Tsoucas DM; Le Guen CL; Hand NJ; Friedman JR
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G803-12. PubMed ID: 25147232
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis of eosinophilic esophagitis by gene expression profiling.
Wen T; Stucke EM; Grotjan TM; Kemme KA; Abonia JP; Putnam PE; Franciosi JP; Garza JM; Kaul A; King EC; Collins MH; Kushner JP; Rothenberg ME
Gastroenterology; 2013 Dec; 145(6):1289-99. PubMed ID: 23978633
[TBL] [Abstract][Full Text] [Related]
5. MiR-4668 as a Novel Potential Biomarker for Eosinophilic Esophagitis.
Bhardwaj N; Sena M; Ghaffari G; Ishmael F
Allergy Rhinol (Providence); 2020; 11():2152656720953378. PubMed ID: 32923026
[TBL] [Abstract][Full Text] [Related]
6. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.
Martin LJ; Franciosi JP; Collins MH; Abonia JP; Lee JJ; Hommel KA; Varni JW; Grotjan JT; Eby M; He H; Marsolo K; Putnam PE; Garza JM; Kaul A; Wen T; Rothenberg ME
J Allergy Clin Immunol; 2015 Jun; 135(6):1519-28.e8. PubMed ID: 26051952
[TBL] [Abstract][Full Text] [Related]
8. Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.
Rochman M; Travers J; Miracle CE; Bedard MC; Wen T; Azouz NP; Caldwell JM; Kc K; Sherrill JD; Davis BP; Rymer JK; Kaufman KM; Aronow BJ; Rothenberg ME
J Allergy Clin Immunol; 2017 Sep; 140(3):738-749.e3. PubMed ID: 28104354
[TBL] [Abstract][Full Text] [Related]
9. Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing.
Sherrill JD; Kiran KC; Blanchard C; Stucke EM; Kemme KA; Collins MH; Abonia JP; Putnam PE; Mukkada VA; Kaul A; Kocoshis SA; Kushner JP; Plassard AJ; Karns RA; Dexheimer PJ; Aronow BJ; Rothenberg ME
Genes Immun; 2014 Sep; 15(6):361-9. PubMed ID: 24920534
[TBL] [Abstract][Full Text] [Related]
10. One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis.
Ackerman SJ; Kagalwalla AF; Hirano I; Gonsalves N; Katcher PM; Gupta S; Wechsler JB; Grozdanovic M; Pan Z; Masterson JC; Du J; Fantus RJ; Alumkal P; Lee JJ; Ochkur S; Ahmed F; Capocelli K; Melin-Aldana H; Biette K; Dubner A; Amsden K; Keeley K; Sulkowski M; Zalewski A; Atkins D; Furuta GT
Am J Gastroenterol; 2019 Oct; 114(10):1614-1625. PubMed ID: 31567192
[TBL] [Abstract][Full Text] [Related]
11. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
[TBL] [Abstract][Full Text] [Related]
12. Normalized serum eosinophil peroxidase levels are inversely correlated with esophageal eosinophilia in eosinophilic esophagitis.
Wright BL; Ochkur SI; Olson NS; Shim KP; Jacobsen EA; Rank MA; Dellon ES; Lee JJ
Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29228243
[TBL] [Abstract][Full Text] [Related]
13. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.
Rothenberg ME; Wen T; Greenberg A; Alpan O; Enav B; Hirano I; Nadeau K; Kaiser S; Peters T; Perez A; Jones I; Arm JP; Strieter RM; Sabo R; Gunawardena KA
J Allergy Clin Immunol; 2015 Feb; 135(2):500-7. PubMed ID: 25226850
[TBL] [Abstract][Full Text] [Related]
14. Low Expression of ICAM-1 in Blood Eosinophils in Patients With Active Eosinophilic Esophagitis.
Perez-Lucendo I; Gomez Torrijos E; Donado P; Melero R; Feo-Brito F; Urra JM
J Investig Allergol Clin Immunol; 2021 Jul; 31(4):316-321. PubMed ID: 31983676
[TBL] [Abstract][Full Text] [Related]
15. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.
Vanoni S; Zeng C; Marella S; Uddin J; Wu D; Arora K; Ptaschinski C; Que J; Noah T; Waggoner L; Barski A; Kartashov A; Rochman M; Wen T; Martin L; Spence J; Collins M; Mukkada V; Putnam P; Naren A; Chehade M; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2020 Jan; 145(1):239-254.e2. PubMed ID: 31647967
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA dysregulation and therapeutic opportunities in esophageal diseases.
Markey GE; Donohoe CL; McNamee EN; Masterson JC
Am J Physiol Gastrointest Liver Physiol; 2023 Jul; 325(1):G1-G13. PubMed ID: 37129237
[TBL] [Abstract][Full Text] [Related]
18. Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis.
Simon D; Page B; Vogel M; Bussmann C; Blanchard C; Straumann A; Simon HU
Allergy; 2018 Jan; 73(1):239-247. PubMed ID: 28712126
[TBL] [Abstract][Full Text] [Related]
19. Salivary microRNAs in pediatric eosinophilic esophagitis.
Jhaveri PB; Lambert KA; Bogale K; Lehman E; Alexander C; Ishmael F; Jhaveri PN; Hicks SD
Allergy Asthma Proc; 2023 Mar; 44(2):145-152. PubMed ID: 36872450
[No Abstract] [Full Text] [Related]
20. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
Doyle AD; Masuda MY; Kita H; Wright BL
Front Immunol; 2020; 11():603295. PubMed ID: 33335531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
